Skip to main content

Advertisement

Log in

Prognostic Implication of Postoperative Weight Loss After Esophagectomy for Esophageal Squamous Cell Cancer

  • Thoracic Oncology
  • Published:
Annals of Surgical Oncology Aims and scope Submit manuscript

Abstract

Background

Preoperative weight loss in esophageal cancer is reported to be associated with a poor prognosis. However, the impact of postoperative weight loss on the prognosis of patients with esophageal cancer remains unclear.

Methods

This study included 186 patients with esophageal squamous cell carcinoma who underwent surgery between January 2012 and January 2015. The relationship between weight loss 6 months after esophagectomy as well as the clinical factors and prognosis of patients was investigated.

Results

The mean weight loss rate for all the patients was 9.3% at 3 months, 10.8% at 6 months, 11.1% at 12 months, and 11.4% at 24 months after surgery. The patients with severe weight loss 6 months after surgery (≥ 12%) exhibited lower serum albumin levels and a lower prognostic nutrition index 6 months after esophagectomy than the patients with moderate weight loss (< 12%; p = 0.011 and 0.009, respectively). Although overall survival did not differ significantly between the two groups, for all the patients, severe weight loss was significantly associated with shortened overall survival for the cStages 3 and 4 patients (3-year overall survival rate, 76.6% in the moderate group vs 54.5% in the severe group; p = 0.042). The multivariate analyses identified only severe weight loss as an independent factor associated with worse overall survival for the cStages 3 and 4 patients (p = 0.034).

Conclusion

This study showed that postoperative weight loss negatively affected the prognosis for patients with advanced esophageal cancer, indicating the necessity of administering nutritional interventions to these patients to prevent postoperative weight loss.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1

Similar content being viewed by others

References

  1. Bollschweiler E, Plum P, Monig SP, Holscher AH. Current and future treatment options for esophageal cancer in the elderly. Expert Opin Pharmacother. 2017;18:1001–10.

    Article  CAS  Google Scholar 

  2. Gockel I, Niebisch S, Ahlbrand C, et al. Risk and complication management in esophageal cancer surgery: a review of the literature. Thorac Cardiovasc Surg. 2016;64:596–605.

    Article  Google Scholar 

  3. Martin L, Lagergren J, Lindblad M, Rouvelas I, Lagergren P. Malnutrition after oesophageal cancer surgery in Sweden. Br J Surg. 2007;94:1496–500.

    Article  CAS  Google Scholar 

  4. Lagergren J, Lagergren P, Recent developments in esophageal adenocarcinoma. CA Cancer J Clin. 2013;63:232–8.

    Article  Google Scholar 

  5. Riccardi D, Allen K, Nutritional management of patients with esophageal and esophagogastric junction cancer. Cancer Control. 1999;6:64–72.

    Article  CAS  Google Scholar 

  6. Anandavadivelan P, Wikman A, Johar A, Lagergren P. Impact of weight loss and eating difficulties on health-related quality of life up to 10 years after oesophagectomy for cancer. Br J Surg. 2018;105:410–8.

    Article  CAS  Google Scholar 

  7. Elliott JA, Docherty NG, Eckhardt HG, et al. Weight loss, satiety, and the postprandial gut hormone response after esophagectomy: a prospective study. Ann Surg. 2017;266:82–90.

    Article  Google Scholar 

  8. Baker M, Halliday V, Williams RN, Bowrey DJ. A systematic review of the nutritional consequences of esophagectomy. Clin Nutr. 2016;35:987–94.

    Article  Google Scholar 

  9. Ludwig DJ, Thirlby RC, Low DE. A prospective evaluation of dietary status and symptoms after near-total esophagectomy without gastric emptying procedure. Am J Surg. 2001;181:454–8.

    Article  CAS  Google Scholar 

  10. Haverkort EB, Binnekade JM, Busch OR, et al. Presence and persistence of nutrition-related symptoms during the first year following esophagectomy with gastric tube reconstruction in clinically disease-free patients. World J Surg. 2010;34:2844–52.

    Article  CAS  Google Scholar 

  11. D’Journo XB, Ouattara M, Loundou A, et al.. Prognostic impact of weight loss in 1-year survivors after transthoracic esophagectomy for cancer. Dis Esophagus. 2012;25:527–34.

    Article  Google Scholar 

  12. Martin L, Lagergren P. Risk factors for weight loss among patients surviving 5 years after esophageal cancer surgery. Ann Surg Oncol. 2015;22:610–6.

    Article  Google Scholar 

  13. Liu J, Xie X, Zhou C, et al. Which factors are associated with actual 5-year survival of oesophageal squamous cell carcinoma? Eur J Cardiothorac Surg. 2012;41:e7–11.

    Article  Google Scholar 

  14. Brierley JD, Gospodarowicz MK, Wittekind C. TNM Classification of Malignant Tumours. 8th ed. Wiley, New York, 2017.

    Google Scholar 

  15. Sugimura K, Miyata, H, Shinno N, et al. Prognostic factors for esophageal squamous cell carcinoma treated with neoadjuvant docetaxel/cisplatin/5-fluorouracil followed by surgery. Oncology. 2019;97:1–8.

    Article  Google Scholar 

  16. Kubo Y, Miyata H, Sugimura K, et al. Prophylactic effect of premedication with intravenous magnesium on renal dysfunction in preoperative cisplatin-based chemotherapy for esophageal cancer. Oncology. 2019;97:319–26.

    Article  CAS  Google Scholar 

  17. Miyata H, Sugimura K, Yamasaki M, et al. Clinical impact of the location of lymph node metastases after neoadjuvant chemotherapy for middle and lower thoracic esophageal cancer. Ann Surg Oncol. 2019;26:200–8.

    Article  Google Scholar 

  18. Miyata H, Sugimura K, Yamasaki M, et al. Clinical implications of conversion surgery after induction therapy for T4b thoracic esophageal squamous cell carcinoma. Ann Surg Oncol. 2019;26:4737–43.

    Article  Google Scholar 

  19. Dindo D, Demartines N, Clavien PA. Classification of surgical complications: a new proposal with evaluation in a cohort of 6336 patients and results of a survey. Ann Surg. 2004;240:205–13.

    Article  Google Scholar 

  20. Onodera T, Goseki N, Kosaki G. Prognostic nutritional index in gastrointestinal surgery of malnourished cancer patients. Nihon Geka Gakkai Zasshi. 1984;85:1001–5.

    CAS  PubMed  Google Scholar 

  21. Kudou K, Saeki H, Nakashima Y, et al. C-reactive protein/albumin ratio is a poor prognostic factor of esophagogastric junction and upper gastric cancer. J Gastroenterol Hepatol. 2019;34:355–63.

    Article  CAS  Google Scholar 

  22. Lagarde SM, de Boer JD, ten Kate FJ, et al. Postoperative complications after esophagectomy for adenocarcinoma of the esophagus are related to timing of death due to recurrence. Ann Surg. 2008;247:71–6.

    Article  Google Scholar 

  23. Takahashi K, Watanabe M, Kozuki R, et al. Prognostic significance of skeletal muscle loss during early postoperative period in elderly patients with esophageal cancer. Ann Surg Oncol. 2019;26:3727–35.

    Article  Google Scholar 

  24. Okada G, Momoki C, Habu D, et al. Effect of postoperative oral intake on prognosis for esophageal cancer. Nutrients. 2019;11:E1338.

    Article  Google Scholar 

  25. Glickman JN, Torres C, Wang HH, et al. The prognostic significance of lymph node micrometastasis in patients with esophageal carcinoma. Cancer. 1999;85:769–78.

    Article  CAS  Google Scholar 

  26. Sato F, Shimada Y, Li Z, et al. Lymph node micrometastasis and prognosis in patients with oesophageal squamous cell carcinoma. Br J Surg. 2001;88:426–32.

    Article  CAS  Google Scholar 

  27. Marti A, Marcos A, Martinez JA. Obesity and immune function relationships. Obes Rev. 2001;2:131–40.

    Article  CAS  Google Scholar 

  28. Ouattara M, D’Journo XB, Loundou A, et al. Body mass index kinetics and risk factors of malnutrition one year after radical oesophagectomy for cancer. Eur J Cardiothorac Surg. 2012;41:1088–93.

    Article  Google Scholar 

  29. Kitagawa H, Namikawa T, Munekage M, et al. Analysis of factors associated with weight loss after esophagectomy for esophageal cancer. Anticancer Res. 2016;36:5409–12.

    Article  Google Scholar 

  30. Schandl A, Kauppila JH, Anandavadivelan P, Johar A, Lagergren P. Predicting the risk of weight loss after esophageal cancer surgery. Ann Surg Oncol. 2019;26:2385–91.

    Article  Google Scholar 

  31. Sugiyama K, Narita Y, Mitani S, et al. Baseline sarcopenia and skeletal muscle loss during chemotherapy affect survival outcomes in metastatic gastric cancer. Anticancer Res. 2018;38:5859–66.

    Article  CAS  Google Scholar 

  32. Nagata M, Ito H, Yoshida T, et al. Risk factors for progressive sarcopenia 6 months after complete resection of lung cancer: what can thoracic surgeons do against sarcopenia? J Thorac Dis. 2020;12:307–318.

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Hiroshi Miyata MD.

Ethics declarations

Disclosure

There are no conflicts of interest.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Electronic Supplementary Material

Below is the link to the electronic supplementary material.

Supplementary material 1 (DOCX 84 kb)

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Kubo, Y., Miyata, H., Sugimura, K. et al. Prognostic Implication of Postoperative Weight Loss After Esophagectomy for Esophageal Squamous Cell Cancer. Ann Surg Oncol 28, 184–193 (2021). https://doi.org/10.1245/s10434-020-08762-6

Download citation

  • Received:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1245/s10434-020-08762-6

Navigation